A Prospective, Randomized Trial of Intravenous Prochlorperazine Versus Subcutaneous Sumatriptan in Acute Migraine Therapy in the Emergency Department

Annals of Emergency Medicine

Volumn 56, Issue 1, 2010, Pages 1-6

  Kostic, Mark A ^a,b   Gutierrez, Francisco J ^a   Rieg, Thomas S ^a   Moore, Tammy S ^a   Gendron, Richard T ^a  

^a NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; PLACEBO; PROCHLORPERAZINE MALEATE; SUMATRIPTAN SUCCINATE;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMERGENCY WARD; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESTLESSNESS; SEDATION; THORAX PAIN; VISUAL ANALOG SCALE;

ADULT; AKATHISIA, DRUG-INDUCED; ANALGESICS; CONSCIOUS SEDATION; DIPHENHYDRAMINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, SUBCUTANEOUS; MALE; MIGRAINE DISORDERS; NAUSEA; PAIN MEASUREMENT; PROCHLORPERAZINE; PROSPECTIVE STUDIES; RECURRENCE; SUMATRIPTAN;

EID: 77953610308     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2009.11.020     Document Type: Article

References (25)

1. Callan J.E., Kostic M.A., Bachrach E.A., et al. Prochlorperazine vs promethazine for headache treatment in the emergency department: a randomized controlled trial. J Emerg Med 35 (2008) 247-253
2. Seim M.B., March J.A., and Dunn K.A. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med 5 (1998) 573-576
3. Tanen D.A., Miller S., and French T. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med 41 (2003) 847-853
4. Brousseau D.C., Duffy S.J., Anderson A.C., et al. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med 43 (2004) 256-262
5. Kabbouche M.A., Vockell A.B., LeCates S.L., et al. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics 107 (2001) e62
6. Vinson D.R., and Drotts D.L. Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial. J Emerg Med 26 (2004) 265-270
7. Landy S., DeRossett S.E., Rapoport A., et al. Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes. Medscape Gen Med 9 (2007) 53
8. Barbanti P., Le Pera D., and Cruccu G. Sumatriptan fast-disintegrating/rapid release tablets in the acute treatment of migraine [review]. Expert Rev Neurother 7 (2007) 927-934
9. Miner J.R., Smith S.W., Moore J., et al. Sumatriptan for the treatment of undifferentiated primary headaches in the ED. Am J Emerg Med 25 (2007) 60-64
10. Tfelt-Hanson P., Bach F.W., Daugaard D., et al. Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study. J Headache Pain 7 (2006) 389-394
11. Cady R., and Schreiber C. Sumatriptan: update and review [review]. Expert Opin Pharmacother 7 (2006) 1503-1514
12. Friedman B.W., Corbo J., Lipton R.B., et al. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology 64 (2005) 463-468
13. Sandrini G., Cerbo R., Del Bene E., et al. Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine, and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study. Int J Clin Pract 61 (2007) 1256-1269
14. Gillian C.H., Brown M.M., Mo J., et al. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 62 (2004) 563-568
15. Mathew N.T., and Loder E.W. Evaluating the triptans. Am J Med 118 suppl 1 (2005) 28S-35S
16. Donohue C., Thomas S.H., and Benson C.K. Prochlorperazine versus sumatriptan for emergency department therapy of migraine headache. Ann Emerg Med 25 (1995) 154-155
17. Goldstein J., Camargo Jr. C.A., Pelletier J., et al. Headache in United States emergency departments: demography, work up and frequency of pathological diagnoses. Cephalalgia 26 (2006) 684-690
18. Vinson D.R. Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med 39 (2002) 215-222
19. Todd K.H., Funk K.G., Funk J.P., et al. Clinical significance of reported changes in pain severity. Ann Emerg Med 27 (1996) 485-489
20. Gallagher E.J., Liebman M., and Bijur P.E. Prospective evaluation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med 38 (2001) 633-638
21. Burstein R., Cutrer M.F., and Yarnitsky D. The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123 (2000) 1703-1709
22. Peroutka S. Dopamine and migraine. Neurology 49 (1997) 650-656
23. Kelly A., Ardagh M., Curry C., et al. Intravenous chlorpromazine versus intramuscular sumatriptan for acute migraine. J Accid Emerg Med 14 (1997) 209-211
24. Goadsby P.J., Lipton R.B., and Ferrari M.D. Migraine: current understanding and treatment. N Engl J Med 346 (2002) 257-270
25. van Zanten A.R.H., Engelfriet P.M., van Dillen K., et al. Importance of nondrug costs of intravenous antibiotic therapy. Crit Care 7 (2003) 184-190